BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 20646746)

  • 1. Resistive index as risk factor for acute urinary retention in patients with benign prostatic hyperplasia.
    Shinbo H; Kurita Y; Takada S; Imanishi T; Otsuka A; Furuse H; Nakanishi T; Mugiya S; Ozono S
    Urology; 2010 Dec; 76(6):1440-5. PubMed ID: 20646746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of resistive index of the prostate and bladder sonomorphologic parameters as replacements for urodynamics to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Garg G; Sankhwar SN; Goel A; Pandey S; Sharma D; Parihar A
    Low Urin Tract Symptoms; 2019 May; 11(3):163-168. PubMed ID: 30793849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
    Milonas D; Trumbeckas D
    Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary bladder characteristics via ultrasound as predictors of acute urinary retention in men with benign prostatic hyperplasia.
    Ho CC; Ngoo KS; Hamzaini AH; Rizal AM; Zulkifli MZ
    Clin Ter; 2014; 165(2):75-81. PubMed ID: 24770808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistive index: a newly identified predictor of outcome of transurethral prostatectomy in patients with benign prostatic hyperplasia.
    Shinbo H; Kurita Y; Nakanishi T; Imanishi T; Otsuka A; Furuse H; Mugiya S; Ozono S
    Urology; 2010 Jan; 75(1):143-7. PubMed ID: 19854491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
    Chan CK; Yip SK; Wu IP; Li ML; Chan NH
    BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic measurement of bladder weight as a possible predictor of acute urinary retention in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Miyashita H; Kojima M; Miki T
    Ultrasound Med Biol; 2002 Aug; 28(8):985-90. PubMed ID: 12217433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transition zone index as a risk factor for acute urinary retention in benign prostatic hyperplasia.
    Kurita Y; Masuda H; Terada H; Suzuki K; Fujita K
    Urology; 1998 Apr; 51(4):595-600. PubMed ID: 9586613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
    Park SC; Lee JW; Rim JS
    Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of the parameters of prostate volume measured by TRUS in evaluating bladder outlet obstruction].
    Wang Y; Pei F
    Zhonghua Nan Ke Xue; 2003 Oct; 9(7):522-3, 526. PubMed ID: 14628604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of acute urine retention in patients with benign prostate hyperplasia].
    Zhang Y; He L; Long Z; Sun X; Wang G; Pei X; Zhong K; Ye Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):300-4. PubMed ID: 22561500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum PSA and transition zone index as predictors of acute urinary retention in benign prostate hyperplasia].
    Zhu S; Chen S; Li Q; Lin Z; Zheng S; Weng M
    Zhonghua Nan Ke Xue; 2004 Jan; 10(1):24-5. PubMed ID: 14979202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms.
    Ku JH; Ko DW; Cho JY; Oh SJ
    Urology; 2010 Jun; 75(6):1467-71. PubMed ID: 19962734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
    Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
    Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T; Qi J; Yu YJ; Xu D; Jiao Y; Kang J; Chen YQ; Zhu YK
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
    Roehrborn CG; McConnell JD; Saltzman B; Bergner D; Gray T; Narayan P; Cook TJ; Johnson-Levonas AO; Quezada WA; Waldstreicher J;
    Eur Urol; 2002 Jul; 42(1):1-6. PubMed ID: 12121721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Diagnosis of Benign Prostatic Obstruction: Validation of the Young Academic Urologist Clinical Nomogram.
    De Nunzio C; Lombardo R; Gacci M; Milanesi M; Cancrini F; Tema G; Cocci A; Giordano G; Leonardo C; Carini M; Tubaro A
    Urology; 2015 Nov; 86(5):1032-6. PubMed ID: 26284594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of transition zone index in predicting acute urinary morbidity after 125I prostate brachytherapy.
    Crook J; Toi A; McLean M; Pond G
    Brachytherapy; 2002; 1(3):131-7. PubMed ID: 15090275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
    Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
    Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.